Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

INSTITUTO GRIFOLS SA

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

Phase 3

Withdrawn

Conditions: Congenital Afibrinogenemia
Hypofibrinogenemia

Interventions: Biological: FIB Grifols

First Posted Date: 2020-11-19

Last Posted Date: 2023-10-23

Lead Sponsor: Instituto Grifols, S.A.

Registration Number: NCT04636268

A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

Phase 2

Completed

Conditions: COVID-19

Interventions: Biological: Convalescent anti-SARS-CoV-2 MBT Plasma
Drug: Standard Medical Treatment

First Posted Date: 2020-09-14

Last Posted Date: 2021-03-03

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 200

Registration Number: NCT04547127

Locations: 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇪🇸
Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain

and more 9 locations

Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19

Phase 2

Completed

Conditions: COVID-19

Interventions: Biological: Prolastin
Drug: Standard Medical Treatment

First Posted Date: 2020-07-31

Last Posted Date: 2021-07-08

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 100

Registration Number: NCT04495101

Locations: 🇪🇸
Hospital Universitario de Burgos, Burgos, Castilla León, Spain
🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Spain
🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain

and more 6 locations

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

Phase 2

Completed

Conditions: COVID-19

Interventions: Biological: Intravenous Immune Globulin
Drug: Standard Medical Treatment

First Posted Date: 2020-06-16

Last Posted Date: 2021-03-10

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 100

Registration Number: NCT04432324

Locations: 🇪🇸
Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain
🇪🇸
Hospital Germans Trias i Pujol, Badalona, Spain
🇪🇸
Hospital Del Mar, Barcelona, Spain

and more 7 locations

A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Participants

Phase 3

Completed

Conditions: Excessive Bleeding During Surgery

Interventions: Biological: Fibrin Sealant Grifols
Biological: EVICEL

First Posted Date: 2018-03-12

Last Posted Date: 2023-04-14

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 186

Registration Number: NCT03461406

Locations: 🇺🇸
Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
University of Michigan, Michigan Center, Michigan, United States
🇺🇸
The Urological Institute of Northeastern New York, Albany, New York, United States

and more 37 locations

Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Biological: Albumin

First Posted Date: 2015-06-24

Last Posted Date: 2020-06-16

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 13

Registration Number: NCT02479802

Locations: 🇪🇸
Hospital Universitari Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome

Phase 2

Terminated

Conditions: Post-polio Syndrome

Interventions: Biological: Flebogamma 5% DIF
Drug: Placebo

First Posted Date: 2014-06-27

Last Posted Date: 2023-11-27

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 191

Registration Number: NCT02176863

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States
🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

and more 18 locations

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery

Phase 2

Completed

Conditions: Hemostasis

Interventions: Biological: Human thrombin
Biological: Bovine thrombin

First Posted Date: 2013-12-18

Last Posted Date: 2017-06-14

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 181

Registration Number: NCT02014402

Locations: 🇺🇸
805, Tucson, Arizona, United States
🇺🇸
602, Los Angeles, California, United States
🇺🇸
700, 801, Pasadena, California, United States

and more 17 locations

Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries

Phase 3

Completed

Conditions: Parenchymous Tissue Surgical Bleeding

Interventions: Device: Surgicel®
Biological: Fibrin Sealant Grifols

First Posted Date: 2012-12-21

Last Posted Date: 2017-02-08

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 325

Registration Number: NCT01754480

Locations: 🇺🇸
224, Loma Linda, California, United States
🇺🇸
214, Los Angeles, California, United States
🇺🇸
213, New Haven, Connecticut, United States

and more 30 locations

Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Surgery

Phase 3

Completed

Conditions: Vascular Surgical Bleeding

Interventions: Biological: Fibrin Sealant Grifols
Procedure: Manual Compression

First Posted Date: 2012-08-10

Last Posted Date: 2017-04-06

Lead Sponsor: Instituto Grifols, S.A.

Target Recruit Count: 225

Registration Number: NCT01662856

Locations: 🇺🇸
407, Florence, Alabama, United States
🇺🇸
125, Palo Alto, California, United States
🇺🇸
119, San Diego, California, United States

and more 35 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy